A Year in Review
Milestones and Memories:
A recap of our Labcorp Oncology Medical Affairs team’s standout memories from 2023
As we approach the end of 2023, we wanted to take a moment to express our gratitude for your continued engagement and partnership with Labcorp Oncology. The year has been full of innovative science, emerging oncology biomarkers and we are thrilled to share some highlights with you.
By the Numbers
The impact of single gene testing (SGT) on subsequent comprehensive genomic profiling (CGP) success in community oncology practice for advanced non-small cell lung cancer (NSCLC): Results from a prospective observational reference laboratory testing program
We presented our real-world data at ASCO and showed that prior single gene testing limits the performance of CGP and negatively impacts CGP turn around time and the identification of therapeutically relevant genomic variants in non-small cell lung cancer. Performing tissue based CGP as the primary testing strategy is warranted. Congratulations to first author, Mary K. Nesline, and the team.
Performance Assessment of the Labcorp® Plasma Complete™ Test for Comprehensive Genomic Profiling of Solid Tumors Through Liquid Biopsy
Our poster documenting the validation of our new liquid biopsy test for solid tumors was highlighted at AMP Annual Meeting. Presented by first author, Ellen Verner, the Labcorp Plasma Complete test is highly specific and may be used to detect genomic alterations using plasma (blood draw) from patients with solid tumors.
In Case you missed it
Featured Oncology Webinars
We remain committed to continuous education and keeping you up-to-date about emerging biomarkers and best practices. In case you missed them, here is a snapshot of webinars presented this year. Our own internal subject matter experts and thought leaders provide insights into targetable biomarkers and foster meaningful discussions with patients, oncologists and pathologists. We are proud to have created a virtual learning space where you can learn more virtually at your pace within your own space.
In Case you missed it
Highlights from peer-reviewed manuscripts
Throughout the year, we’ve focused on innovation and advancing scientific discovery. We have been working hard to publish on a diverse range of topics that we believe will improve your clinical practice. Here is a snapshot of four high-impact manuscripts with links to the full text and graphical one page summaries for your review.
Best wishes for a healthy 2024!
As we reflect on our year, we extend our gratitude and warm wishes to you, your loved ones, colleagues and patients. Thank you for being an essential part of our journey at Labcorp Oncology. We’re looking forward to 2024!